|
|
2015 Featured Talks » Keynote Presentation: Cancer Genomics: Turning Discovery into Translation
Elaine Mardis, part 1 from MCC Industry Relations on Vimeo.
Elaine Mardis, part 2 from MCC Industry Relations on Vimeo.
Elaine Mardis, part 3 from MCC Industry Relations on Vimeo.
Elaine Mardis, part 4 from MCC Industry Relations on Vimeo.
Elaine R. Mardis, PhD
Robert E. and Louise F. Dunn Distinguished Professor of Medicine
Co-Director, The Genome Institute of Washington University School of Medicine
Dr. Elaine Mardis graduated Phi Beta Kappa from the University of Oklahoma with a B.S. degree in zoology. She then completed her Ph.D. in Chemistry and Biochemistry in 1989, also at Oklahoma. Following graduation, Dr. Mardis was a senior research scientist for four years at BioRad Laboratories in Hercules, CA.
In 1993, Dr. Mardis joined The Genome Institute at Washington University School of Medicine. As Director of Technology Development, she helped create methods and automation pipelines for sequencing the Human Genome. She now serves as Co-director of The Genome Institute.
Dr. Mardis has research interests in the application of next-generation sequencing to characterize cancer genomes and transcriptomes, and using these data to support therapeutic decision-making. She also is interested in facilitating the translation of basic science discoveries about human disease into the clinical setting. br>
Dr. Mardis serves as an editorial board member of Molecular Cancer Research, Disease Models and Mechanisms and Annals of Oncology, and acts as a reviewer for Nature, the New England Journal of Medicine, Cell and Genome Research. In 2014, she was named as the Robert E. and Louise F. Dunn Distinguished Professor of Medicine. She serves on the scientific advisory boards of Qiagen Ingenuity, DNA Nexus, and ZS Genetics, and is a member of the Supervisory Board of Qiagen N.V. Dr. Mardis received the Scripps Translational Research award for her work on cancer genomics in 2010, and was named a Distinguished Alumni of the University of Oklahoma College of Arts and Sciences for 2011. Discover Magazine featured her work in cancer genomics as one of their top 100 science stories in 2013.
|
